AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Intaglip-M Tablet

Prescription Icon
Prescription Required

Marketer

Intas Pharmaceuticals Ltd

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Intaglip-M Tablet

Diabetic patients with type 2 mellitus may find relief from elevated blood glucose levels with the dual-action Intaglip-M Tablet. This medication helps mitigate serious diabetic complications like vision impairment and kidney disease, potentially lowering the risk of cardiovascular events such as stroke or heart attack. Intaglip-M may be used independently or in conjunction with other anti-diabetic therapies. Optimal efficacy requires adherence to a balanced diet and consistent physical activity. Dosage is personalized based on individual health status, blood glucose readings, and existing medications. Consuming the tablet with food minimizes gastrointestinal upset. Consistent daily intake, at the same time each day, maximizes therapeutic benefit and should only cease upon physician instruction. Effective blood sugar management prevents future complications. Continued compliance with the recommended dietary and exercise plan remains crucial. Lifestyle choices significantly impact diabetes control. Commonly reported adverse effects include nausea, diarrhea, vomiting, stomach discomfort, headache, pharyngitis, asthenia, GERD, diaphoresis, and anorexia. Hypoglycemia is a potential side effect, particularly when combined with insulin or sulfonylureas; prompt recognition and management are essential. This medication isn't universally suitable. Individuals with pre-existing liver, kidney, or heart disease, pancreatic issues, or significant alcohol consumption should inform their doctor prior to commencing treatment. Pregnant or lactating women require medical consultation before use. Potential drug interactions exist; a complete medication list should be provided to the physician for safety assurance. Alcohol should be avoided due to its hypoglycemic effect. Regular monitoring of renal function and blood glucose levels will be conducted by your physician throughout the treatment period.

Primary Ingredients of Intaglip-M Tablet

No information provided. Please provide the text you wish to be rewritten.

Uses of Intaglip-M Tablet

Managing type 2 diabetes

Major Benefits of Intaglip-M Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not crush, chew, or fracture it. Intaglip-M Tablets should be administered with food.

Common Side effects of Intaglip-M Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Intaglip-M Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the tablet whole; do not chew, crush, or fracture it. Intaglip-M Tablets should be administered with a meal.

How Intaglip-M Tablet works:

Intaglip-M tablets contain a dual antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol consumption while taking Intaglip-M Tablets.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Intaglip-M Tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Lactation and Intaglip-M Tablet use appear incompatible due to potential infant risk. Available evidence from human studies indicates the medication's possible transfer to breast milk, posing a threat to the nursing infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Intaglip-M Tablets cautiously, potentially requiring a modified dosage. Physician consultation is advised.

LiverLiverUNSAFE

Use of Intaglip-M Tablets is potentially hazardous for individuals with hepatic impairment and is best avoided. Medical advice is recommended.

What if you forget to take Intaglip-M Tablet :

Should you forget a dose of Intaglip-M Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Intaglip-M Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Intaglip-M Tablet

Intaglip-M Tablets rarely cause hypoglycemia by themselves; however, low blood sugar can result from inadequate caloric intake while using this medication. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness may indicate hypoglycemia, particularly if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Intaglip-M Tablets may cause nausea and vomiting. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without first talking to your doctor.
Intaglip-M Tablets are contraindicated in patients allergic to any ingredient or excipient. This medication should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Intaglip-M Tablet combines the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Intaglip-M Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates avoidance in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Seek immediate medical attention and discontinue Intaglip-M if these symptoms occur.
Prolonged use of Intaglip-M Tablets can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Intaglip-M Tablets are safe when used as directed by your doctor. However, even with correct usage, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (hypoglycemia, especially if also taking insulin or sulphonylurea). Report any persistent issues to your physician.
Intaglip-M Tablet
105
MRP 122
13% off